NURS FPX 6021 Assessment 3 Quality Improvement Presentation Poster 

Abstract 

It addresses quality enhancement action, the erected-in-check-act (PDCA) cycle in the scheme, and complex biopsychosocial complications that reduce diabetes and order failure operations as a marshaling point with Mrs. Smith’s case. The design aims to optimize patient issues through a collaborative approach involving continuous glucose monitoring (CGM) performance, comprehensive education, and financial aid strategies. 

The effectiveness of the intervention is bettered by integrating explicatory collaboration and by incorporating an endocrinologist, children’s directors, dietists, and social workers. Benefits are anticipated in terms of an increase in design, better care quality, and streamlined health processes, contributing to wider population health progress. The purpose of this action is to drive nonstop progress in patient care and general distribution of the health care system through continuous evaluation and adaptation. 

Quality Improvement Methods

To promote continuous growth in dealing with diabetes and organ failure, especially for cases similar to Mrs. Smith’s, we propose exercising the PDCA cycle. This system involves four pivotal ways: planning the intervention, administering the plan, checking the results, and acting on what is learned to upgrade the process. In Mrs. Smith’s case, PDCA can be applied to cover and adjust her blood glucose situations and renal function. For example, the original plan may involve introducing CGM and diuretics (Yi et al., 2023). 

The “do” phase will use these interventions, while the “check” phase involves regular monitoring of blood sugar and renal function tests. The “act” phase would use the gathered data to tweak the intervention, ensuring continuous improvement. This cyclical approach ensures that acclimations can be made predicated on real-time data, thereby addressing her care’s physiological (natural) and behavioral (psychosocial) aspects. The PDCA cycle promotes a structured yet flexible frame that promotes the continuous growth that can continuously unite (Yi et al., 2023). 

Limitations of PDCA

Despite its strength, the PDCA cycle presents several challenges. One significant limitation is the eventuality of resistance to change, particularly from cases who may find new technologies like CGM bothersome or clumsy. To palliate this, comprehensive education and support systems need to be established. Cases should be fully educated about the benefits and use of CGM, and support from healthcare professionals should be readily available to address any enterprises (Sugandh et al., 2023). Also, financial walls may hinder the harmonious performance of interventions, especially for cases like Mrs. Smith, who face profitable constraints. 

Connecting cases to financial backing programs can help overcome this barricade (Du et al., 2022). Also, a multidisciplinary approach is needed to handle biopsychosocial ideas to manage the PDCA cycle, to address all aspects of the case status, and to integrate input from endocrinologists, nephrologists, dietitians, and socioeconomists. This collaboration ensures that the intervention is general and case-centered. The PDCA cycle can effectively smooth the continuous quality growth in dealing with complex conditions similar to diabetes and organ failure (you et al., 2022) by estimating these challenges and developing nonstop strategies to address them. 

Evidence-Supported QI Methods

Validation supports the effectiveness of the PDCA cycle in managing diabetes and renal failure in cases like Mrs. Smith’s. CGM has been shown to significantly improve glycemic control by furnishing real-time feedback, enabling timely interventions and acclimations to insulin remedy (Martens et al., 2021). Studies demonstrate that CGM stoners substantiate lower circumstances of hypoglycemia and better overall glucose operation, which directly supports the “check” and “act” phases of the PDCA cycle. 

Likewise, the use of diuretics to manage renal function is backed by guidelines from the American Diabetes Association (ADA), which recommends diuretics for cases with edema and early-stage renal damage to help further deterioration (Afify et al., 2023). This validation reinforces the planning and performance stages of the PDCA cycle, ensuring that the interventions are both validation-predicated and practical. 

The most precious validation for our design includes the ADA guidelines and the disquisition by Martens et al. (2021), as these sources give robust data supporting the integration of CGM and diuretics into the care plan. This validation informs the specific QI approach by validating the chosen interventions and ensuring they are aligned with best practices for managing diabetes and renal failure, thereby enhancing patient issues like Mrs. Smith’s. 

Identify Knowledge Gap 

While validation supports the effectiveness of CGM and diuretics, there may be gaps in understanding how these interventions translate into long-term issues for cases like Mrs. Smith. Also, the optimal frequency and duration of CGM operation in managing blood glucose situations still need to be clarified in specific surroundings. Further disquisition could explore the impact of socioeconomic factors on medicine adherence and its commerce with financial backing programs in perfecting health issues for diabetic cases (Kvarnström et al., 2021). 

Change Strategy Foundation 

The design is anchored in successful change strategies analogous to CGM, financial backing for medicine adherence, diuretics, and comprehensive education (Kvarnström et al., 2021). These strategies are informed by validation-predicated practices and guidelines from estimable sources like the ADA and NANDA (ADA, 2022; NANDA, 2020). Successful performance of CGM and medicine-backing programs has been demonstrated in similar QI systems, showcasing their effectiveness in perfecting patient issues. 

For illustration, CGM helps maintain blood glucose situations within the target range, reducing spikes from 200-350 mg/dL to 80-130 mg/dL fasting and lower than 180 mg/dL postprandial (Lin et al., 2021). These strategies are applicable for this QI design as they address specific clinical conditions analogous to controlling blood glucose situations, managing renal function, and increasing medicine adherence in cases like Mrs. Smith, increasing a comprehensive and validation-predicated approach to quality improvement (Lin et al., 2021). 

Potential Challenges and Solutions 

Administering CGM and financial backing programs faces challenges analogous to original costs and patient acceptance. To address these challenges, healthcare professionals will implement comprehensive strategies and provide ongoing support. Uniting with financial relief associations and social associations can help reduce the duty walls. Resistance to change and adherence issues arise, taking adapted educational interventions and close monitoring of patient progress. Regular feedback and quality improvement assessments will help identify and address arising challenges throughout the performance process (Lin et al., 2021). 

Effectiveness of Interprofessional Teamwork 

The interprofessional team for this QI design will include endocrinologists, nurses, dietitians, social workers, and nephrologists. The collaboration between these different places ensures a comprehensive approach to meet the protean requirements of issues similar to Mrs. Smith, which presents complex biopsychical ideas. By pooling their moxie, team members can contribute specialized knowledge and chops to develop adapted interventions for diabetes operation and give holistic care to renal failure cases like Mrs. Smith. This collaborative approach enhances the design’s quality and effectiveness and promotes a shared understanding of case conditions and pretensions, leading to further case-centered care (Nurchis et al., 2022). 

Also, interprofessional cooperation streamlines communication and collaboration among team members, reducing duplication of efforts and enhancing design effectiveness. By using each team member’s strengths and resources, the design can achieve its objects more swiftly and effectively, ultimately perfecting patient issues and satisfaction. Hypotheticals for the interprofessional cooperation approach include the vacuity and amenability of all team members to unite effectively. Also, it assumes respectable resources and support for interprofessional communication and collaboration throughout the design. Ultimately, it presupposes that each team member possesses the necessary chops and moxie to contribute effectively to the diabetes operation design’s pretensions for cases like Mrs. Smith (Ernawati et al., 2021). 

Overall, the project benefits 

The design benefits include better patient issues through optimized operation of diabetes and renal failure, leading to enhanced quality of life for individuals like Mrs. Smith. Also, the design fosters a culture of continuous improvement within the healthcare setting, promoting better patient safety and equity in care delivery. The design aims to reduce healthcare differences and enhance overall population health by addressing biopsychosocial considerations completely. Also, the design’s emphasis on interprofessional collaboration fosters a more cohesive healthcare team, leading to lower job satisfaction and professional development among staff (Ernawati et al., 2021). Ultimately, these cooperative advancements contribute to a more effective healthcare system, abetting cases like Mrs. Smith’s and healthcare providers. 

NURS FPX 6021 Assessment 3 Quality Improvement Presentation Poster

Kvarnström, K., Westerholm, A., Airaksinen, M., and Liira, H. (2021). Factors that contribute to the observance of the medicine in cases with habitual conditions: a scoping review of qualitative exploration. Pharmaceutics, 13(7).  https://doi.org/10.3390/pharmaceutics13071100 

Lynn, R., Brown, F., James, S., Jones, J., and Ekmani, E. (2021). Constant glucose monitoring Review of substantiation in types 1 and 2 diabetes mellitus. Diabetic drug, 38(5). https://doi.org/10.1111/dme.14528 

Martens, T., Singe, R. W., Bailey, R., Ruid, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Timikas, A., Baa, S. T., Orozco, I., Bigs, W., and Lucas, K. (2021). The effect of nonstop glucose monitoring on glycemic control in cases with type 2 diabetes treated with rudimentary insulin. Jama, 325(22). https://doi.org/10.1001/jama.2021.7444  

NANDA (2020, October 6). NANDA International Nursing Judgments, Inc. NANDA. https://nanda.org/publications-resources/publications/nanda-international-nursing-diagnoses/ 

NURS FPX 6021 Assessment 3 Quality Improvement Presentation Poster

Narchis, M. C., Sesa, G., Paskuchi, D., Sasano, M., Lombi, L., and Demiani, G. (2022). Interaction in primary care and diabetes treatment: a methodical review and meta-analysis of case-reported results. Personal Medical Journal, 12(4).  https://doi.org/10.3390/jpm12040643 

Scent, F. N. U., Chandio, M., Rava, F. N. U., Kumar, L., Karishma, F. N. U., Khuwaja, S., Memon, U. A. A. Kumar, L., Karishma, F. N. U., Khuwaja, S., Memon, U. A. Progress in handling diabetes mellitus: Focus on a particular drug. Cureus, 15(8), 1-13. https://doi.org/10.7759/cureus.43697 

Yi, Z., Uni, G. A. O., Sheyu, L. I., Nanwei, T., Min, C., Dajiang, L. I., Yan, J., Weyi, Z., & Xiangjun, C. (2023). Perform active blood sugar operation during hospitalization grounded on the PDCA cycle. A practical study A practical study. Chinese General Practice, 26(15). https://doi.org/10.12114/j.issn.1007-9572.2022.0821